A Novel RHEB Germline Variant Associated With Intellectual Disability and Epilepsy: Expanding the Spectrum of mTORopathies
ABSTRACT The mTOR cascade is a critical player in the pathogenesis of focal epilepsies and cortical malformations, collectively referred to as mTORopathies. The Ras homolog enriched in brain (RHEB) gene is a member of the RAS‐family GTPases and a potent activator of the mechanistic target of rapamyc...
Saved in:
Published in | Clinical genetics Vol. 108; no. 2; pp. 218 - 223 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-9163 1399-0004 1399-0004 |
DOI | 10.1111/cge.14734 |
Cover
Summary: | ABSTRACT
The mTOR cascade is a critical player in the pathogenesis of focal epilepsies and cortical malformations, collectively referred to as mTORopathies. The Ras homolog enriched in brain (RHEB) gene is a member of the RAS‐family GTPases and a potent activator of the mechanistic target of rapamycin complex (mTORC1). Brain somatic variants in the RHEB gene have been described in patients affected by focal cortical dysplasia and hemimegalencephaly abnormalities. Conversely, germline genetic variants in the RHEB gene have been poorly reported in patients with neurodevelopmental disorders. This study describes the phenotype of a patient with global developmental delay and epilepsy carrying a novel germline de novo heterozygous missense variant (c.71 T>C; p.Ile24Thr) in the RHEB gene. Previously reported patients are reviewed and compared to the case reported here, expanding the genotype and phenotype spectrum of mTORopathies.
The mTOR cascade is a critical player in the pathogenesis of focal epilepsies and cortical malformations, collectively referred to as mTORopathies. We report a novel germline de novo heterozygous missense variant (c.71 T>C; p.Ile24Thr) in the RHEB gene. Only a few patients have been reported in the literature, and phenotypic features include intellectual disability, epilepsy, and behavioral abnormalities. |
---|---|
Bibliography: | Juan Pablo Trujillo‐Quintero and Anna Brunet‐Vega contributed equally to this study. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0009-9163 1399-0004 1399-0004 |
DOI: | 10.1111/cge.14734 |